Valued at a market cap of $54.2 billion, AMETEK, Inc. (AME) is a leading global manufacturer of industrial technology solutions and electronic instruments. Berwyn, Pennsylvania-based company solves complex challenges across diverse niche markets, including aerospace, defense, medical, and energy. It is expected to announce its fiscal Q1 earnings for 2026 before the market opens on Thursday, Apr. 30.
Ahead of this event, analysts expect this industrial company to report a profit of $1.90 per share, up 8.6% from $1.75 per share in the year-ago quarter. The company has topped Wall Street’s bottom-line estimates in each of the last four quarters. In Q4 2025, AME’s EPS of $2.01 outpaced the consensus expectations by 3.6%.
For the current fiscal year, ending in December, analysts expect AME to report earnings of $8.04 per share, up 8.2% from $7.43 per share in fiscal 2025. Its EPS is expected to further grow 8.1% year-over-year to $8.69 in fiscal 2027.
AME has soared 51.2% over the past 52 weeks, considerably outpacing both the S&P 500 Index's ($SPX) 34.6% return and the State Street Industrial Select Sector SPDR ETF’s (XLI) 40.2% uptick over the same time period.
Shares of AME closed up marginally on Feb. 3 after the company reported stronger-than-expected Q4 results. It posted adjusted earnings of $2.01 per share and record revenue of $2 billion, both topping analyst estimates. Investor sentiment was further supported by strong cash generation, with record free cash flow of $527.3 million and a high free cash flow–to–net income conversion rate of 132%.
Wall Street analysts are moderately optimistic about AME’s stock, with a "Moderate Buy" rating overall. Among 20 analysts covering the stock, 13 recommend "Strong Buy," one indicates a "Moderate Buy,” and six suggest "Hold." The mean price target for AME is $251.59, indicating a 7.4% potential upside from the current levels.
On the date of publication, Neharika Jain did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.
More news from Barchart
- Astera Labs Stock Jumps on Major Amazon-Anthropic Deal. Should You Buy ALAB Here?
- As China iPhone Shipments Jump 20%, Should You Buy Apple Stock?
- Is a Short Squeeze Breaking Out in Beyond Meat Stock Now?
- Is PayPal an Acquisition Target? How to Play PYPL Stock Right Now Amid Activist Investor Rumors.
